Cerenome is trading 6.12% down at $2.76 after closing at $2.94 on September 2, 2026, with no clear overnight catalyst identified.
- No new company-specific announcement was identified for September 3, 2026.
- Recent coverage says the latest quarterly results missed revenue estimates and reported a wider loss, though that report predates this pre-market move.
- Broader futures are relatively mixed, so the immediate reason remains unclear.